Heart failure reviews

Keyphrases

Publications

volume 29, number 5, 2024

Tanize Louize Milbradt, Francinny Alves Kelly, Marília Oberto da Silva Gobbo, Stephen Akinfenwa, Brenda Moura
Acetazolamide therapy in patients with acute heart failure: a systematic review and meta-analysis of randomized controlled trials. Heart failure reviews 29 (5) (2024)
Konstantinos Sideris, Sotiria Liori
Evaluating the role of interatrial shunt devices in heart failure management: insights from the RELIEVE-HF trial. Heart failure reviews 29 (5) (2024)
Laibah Arshad Khan, Muhammad Shahzeb Khan, Andrew P Ambrosy, Stephen J Greene
Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial. Heart failure reviews 29 (5) (2024)
Jan Biegus, Matteo Pagnesi, Beth Davison, Piotr Ponikowski, Alexander Mebazaa, Gadi Cotter
High-intensity care for GDMT titration. Heart failure reviews 29 (5) (2024)
Weiteng Wang, Hao Jia, Xiumeng Hua, Jiang-Ping Song
New insights gained from cellular landscape changes in myocarditis and inflammatory cardiomyopathy. Heart failure reviews 29 (5) (2024)
Michele Correale, Giuseppe Pelaggi, Maria Concetta Catanoso, Serena Miccichè, Lucio Teresi, Salvatore Bonanno, Paolo Bellocchi, Cristina Poleggi, Raffaele Capasso, Massimo Barile, Valeria Visco, Erberto Carluccio, Savina Nodari, Michele Ciccarelli, Giuseppe Dattilo
Vericiguat in heart failure with reduced ejection fraction: hope or solid reality? Heart failure reviews 29 (5) (2024)
Mieczysław Dutka, Karolina Zimmer, Michał Ćwiertnia, Tomasz Ilczak, Rafał Bobiński
The role of PCSK9 in heart failure and other cardiovascular diseases-mechanisms of action beyond its effect on LDL cholesterol. Heart failure reviews 29 (5) (2024)
Michele Correale, Giuseppe Pelaggi, Maria Concetta Catanoso, Serena Miccichè, Lucio Teresi, Salvatore Bonanno, Paolo Bellocchi, Cristina Poleggi, Raffaele Capasso, Massimo Barile, Valeria Visco, Erberto Carluccio, Savina Nodari, Michele Ciccarelli, Giuseppe Dattilo
Vericiguat in heart failure with reduced ejection fraction: hope or solid reality? Heart failure reviews 29 (5) (2024)
Mahmoud Abbassy, Muhammad Zain Ali, Riya Manas Sharma, Yohan Porus Irani, Adil Dahlan, Maimoona Azhar, Nadeem Aslam, Babar Hasan, Aamir Hameed
Biosensors with left ventricular assist devices. Heart failure reviews 29 (5) (2024)
Alexander Aaron Yacob, Kelsey M Flint
Renal function in PUSH-AHF: a summary of newly released data from the 2024 Annual Congress of the Heart Failure Association of the ESC. Heart failure reviews 29 (5) (2024)
Lingling Wu, Mario Rodriguez, Karim El Hachem, W H Wilson Tang, Chayakrit Krittanawong
Management of patients with heart failure and chronic kidney disease. Heart failure reviews 29 (5) (2024)
Nicola Pradegan, Luigi Di Pasquale, Dario Di Perna, Michele Gallo, Giovanni Lucertini, Marco Gemelli, Thomas Beyerle, Mark S Slaughter, Gino Gerosa
Ex vivo heart perfusion: an updated systematic review. Heart failure reviews 29 (5) (2024)
Phuuwadith Wattanachayakul, Veraprapas Kittipibul, Husam M Salah, Hidenori Yaku, Julio Nuñez, Rafael De la Espriella, Tor Biering-Sørensen, Marat Fudim
Non-invasive heart failure monitoring: leveraging smart scales and digital biomarkers to improve heart failure outcomes. Heart failure reviews 29 (5) (2024)
Hiroaki Hiraiwa, Yoshimitsu Yura, Takahiro Okumura, Toyoaki Murohara
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis. Heart failure reviews 29 (5) (2024)
Sawa Kostin, Florian Krizanic, Theodoros Kelesidis, Nikolaos Pagonas
The role of NETosis in heart failure. Heart failure reviews 29 (5) (2024)
Frans Serpa, Caitlin M Finn, Usman A Tahir
Navigating the penetrance and phenotypic spectrum of inherited cardiomyopathies. Heart failure reviews 29 (5) (2024)
Weiteng Wang, Hao Jia, Xiumeng Hua, Jiang-Ping Song
New insights gained from cellular landscape changes in myocarditis and inflammatory cardiomyopathy. Heart failure reviews 29 (5) (2024)
Majed S Al Yami, Abdulmajeed M Alshehri, Saeed M Alay, Abdulmalik Y Aljoufi, Mariam S Alsulimani, Shatha M Algarni, Sumaya N Almohareb, Awatif M Hafiz, Omar A Alshaya, Amal M Badawoud
Extended thromboprophylaxis in heart failure patients; the unmet need. Heart failure reviews 29 (5) (2024)
Laibah Arshad Khan, Muhammad Shahzeb Khan, Andrew P Ambrosy, Stephen J Greene
Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial. Heart failure reviews 29 (5) (2024)
Satoshi Shoji, Robert J Mentz
Beyond quadruple therapy: the potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentarium. Heart failure reviews 29 (5) (2024)
Tanize Louize Milbradt, Francinny Alves Kelly, Marília Oberto da Silva Gobbo, Stephen Akinfenwa, Brenda Moura
Acetazolamide therapy in patients with acute heart failure: a systematic review and meta-analysis of randomized controlled trials. Heart failure reviews 29 (5) (2024)
Frans Serpa, Caitlin M Finn, Usman A Tahir
Navigating the penetrance and phenotypic spectrum of inherited cardiomyopathies. Heart failure reviews 29 (5) (2024)
Hiroaki Hiraiwa, Yoshimitsu Yura, Takahiro Okumura, Toyoaki Murohara
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis. Heart failure reviews 29 (5) (2024)
Konstantinos Sideris, Sotiria Liori
Evaluating the role of interatrial shunt devices in heart failure management: insights from the RELIEVE-HF trial. Heart failure reviews 29 (5) (2024)
Mieczysław Dutka, Karolina Zimmer, Michał Ćwiertnia, Tomasz Ilczak, Rafał Bobiński
The role of PCSK9 in heart failure and other cardiovascular diseases-mechanisms of action beyond its effect on LDL cholesterol. Heart failure reviews 29 (5) (2024)
Nicola Pradegan, Luigi Di Pasquale, Dario Di Perna, Michele Gallo, Giovanni Lucertini, Marco Gemelli, Thomas Beyerle, Mark S Slaughter, Gino Gerosa
Ex vivo heart perfusion: an updated systematic review. Heart failure reviews 29 (5) (2024)
Sawa Kostin, Florian Krizanic, Theodoros Kelesidis, Nikolaos Pagonas
The role of NETosis in heart failure. Heart failure reviews 29 (5) (2024)
Mieczysław Dutka, Karolina Zimmer, Michał Ćwiertnia, Tomasz Ilczak, Rafał Bobiński
The role of PCSK9 in heart failure and other cardiovascular diseases-mechanisms of action beyond its effect on LDL cholesterol. Heart failure reviews 29 (5) (2024)
Majed S Al Yami, Abdulmajeed M Alshehri, Saeed M Alay, Abdulmalik Y Aljoufi, Mariam S Alsulimani, Shatha M Algarni, Sumaya N Almohareb, Awatif M Hafiz, Omar A Alshaya, Amal M Badawoud
Extended thromboprophylaxis in heart failure patients; the unmet need. Heart failure reviews 29 (5) (2024)
Mahmoud Abbassy, Muhammad Zain Ali, Riya Manas Sharma, Yohan Porus Irani, Adil Dahlan, Maimoona Azhar, Nadeem Aslam, Babar Hasan, Aamir Hameed
Biosensors with left ventricular assist devices. Heart failure reviews 29 (5) (2024)
Mahsa Rahimzadeh, Stephanie Tennstedt, Zouhair Aherrahrou
Nexilin in cardiomyopathy: unveiling its diverse roles with special focus on endocardial fibroelastosis. Heart failure reviews 29 (5) (2024)
Maria Concetta Pastore, Alessandro Campora, Giulia Elena Mandoli, Matteo Lisi, Giovanni Benfari, Federica Ilardi, Alessandro Malagoli, Simona Sperlongano, Michael Y Henein, Matteo Cameli, Antonello D'Andrea, null null
Stress echocardiography in heart failure patients: additive value and caveats. Heart failure reviews 29 (5) (2024)
Katarzyna Matusik, Katarzyna Kamińska, Aleksandra Sobiborowicz-Sadowska, Hubert Borzuta, Kasper Buczma, Agnieszka Cudnoch-Jędrzejewska
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity. Heart failure reviews 29 (5) (2024)
Hiroaki Hiraiwa, Yoshimitsu Yura, Takahiro Okumura, Toyoaki Murohara
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis. Heart failure reviews 29 (5) (2024)
Alexander Aaron Yacob, Kelsey M Flint
Renal function in PUSH-AHF: a summary of newly released data from the 2024 Annual Congress of the Heart Failure Association of the ESC. Heart failure reviews 29 (5) (2024)
Mahmoud Abbassy, Muhammad Zain Ali, Riya Manas Sharma, Yohan Porus Irani, Adil Dahlan, Maimoona Azhar, Nadeem Aslam, Babar Hasan, Aamir Hameed
Biosensors with left ventricular assist devices. Heart failure reviews 29 (5) (2024)
Josephine Harrington
STEP HFpEF DM: a sweet sequel. Heart failure reviews 29 (5) (2024)
Satoshi Shoji, Robert J Mentz
Beyond quadruple therapy: the potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentarium. Heart failure reviews 29 (5) (2024)
Jan Biegus, Matteo Pagnesi, Beth Davison, Piotr Ponikowski, Alexander Mebazaa, Gadi Cotter
High-intensity care for GDMT titration. Heart failure reviews 29 (5) (2024)
Phuuwadith Wattanachayakul, Veraprapas Kittipibul, Husam M Salah, Hidenori Yaku, Julio Nuñez, Rafael De la Espriella, Tor Biering-Sørensen, Marat Fudim
Non-invasive heart failure monitoring: leveraging smart scales and digital biomarkers to improve heart failure outcomes. Heart failure reviews 29 (5) (2024)
Josephine Harrington
Anti-obesity medications in the management of heart failure with preserved ejection fraction: available evidence and next STEPS. Heart failure reviews 29 (5) (2024)
Katarzyna Matusik, Katarzyna Kamińska, Aleksandra Sobiborowicz-Sadowska, Hubert Borzuta, Kasper Buczma, Agnieszka Cudnoch-Jędrzejewska
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity. Heart failure reviews 29 (5) (2024)
Josephine Harrington
Anti-obesity medications in the management of heart failure with preserved ejection fraction: available evidence and next STEPS. Heart failure reviews 29 (5) (2024)
Mahsa Rahimzadeh, Stephanie Tennstedt, Zouhair Aherrahrou
Nexilin in cardiomyopathy: unveiling its diverse roles with special focus on endocardial fibroelastosis. Heart failure reviews 29 (5) (2024)
Maria Concetta Pastore, Alessandro Campora, Giulia Elena Mandoli, Matteo Lisi, Giovanni Benfari, Federica Ilardi, Alessandro Malagoli, Simona Sperlongano, Michael Y Henein, Matteo Cameli, Antonello D'Andrea, null null
Stress echocardiography in heart failure patients: additive value and caveats. Heart failure reviews 29 (5) (2024)
Jan Biegus, Matteo Pagnesi, Beth Davison, Piotr Ponikowski, Alexander Mebazaa, Gadi Cotter
High-intensity care for GDMT titration. Heart failure reviews 29 (5) (2024)
Katarzyna Matusik, Katarzyna Kamińska, Aleksandra Sobiborowicz-Sadowska, Hubert Borzuta, Kasper Buczma, Agnieszka Cudnoch-Jędrzejewska
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity. Heart failure reviews 29 (5) (2024)
Josephine Harrington
STEP HFpEF DM: a sweet sequel. Heart failure reviews 29 (5) (2024)
Lingling Wu, Mario Rodriguez, Karim El Hachem, W H Wilson Tang, Chayakrit Krittanawong
Management of patients with heart failure and chronic kidney disease. Heart failure reviews 29 (5) (2024)
Maria Concetta Pastore, Alessandro Campora, Giulia Elena Mandoli, Matteo Lisi, Giovanni Benfari, Federica Ilardi, Alessandro Malagoli, Simona Sperlongano, Michael Y Henein, Matteo Cameli, Antonello D'Andrea, null null
Stress echocardiography in heart failure patients: additive value and caveats. Heart failure reviews 29 (5) (2024)